Italy Pharmaceuticals Market Summary, Competitive Analysis and Forecast to 2027
Italy Pharmaceuticals Market Summary, Competitive Analysis and Forecast to 2027
Summary
Pharmaceuticals in Italy industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2017-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
Summary
Pharmaceuticals in Italy industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2017-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- The Italian pharmaceuticals market had total revenues of $26.7 billion in 2022, representing a compound annual growth rate (CAGR) of 0.8% between 2017 and 2022.
- 0
- According to in-house research, in 2022, Italy accounted for 26.7% of the European pharmaceuticals market. The growth in the pharmaceutical market is mainly due to an increase in pharmaceutical spending by the government. According to the most recent data available from the OECD, pharmaceutical spending in Italy stood at 17.4% of total health spending in 2022.
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in Italy
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Italy
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Italy pharmaceuticals market with five year forecasts by both value and volume
- What was the size of the Italy pharmaceuticals market by value in 2022?
- What will be the size of the Italy pharmaceuticals market in 2027?
- What factors are affecting the strength of competition in the Italy pharmaceuticals market?
- How has the market performed over the last five years?
- Who are the top competitors in Italy's pharmaceuticals market?
1 EXECUTIVE SUMMARY
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market rivalry
1.5. Competitive landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Who are the leading players?
7.2. What are the strengths of leading players?
7.3. What strategies do leading players follow?
8 COMPANY PROFILES
8.1. Pfizer Inc.
8.2. A Menarini Industrie Farmaceutiche Riunite Srl
8.3. Recordati S.p.A.
8.4. Chiesi Farmaceutici SpA
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market rivalry
1.5. Competitive landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Who are the leading players?
7.2. What are the strengths of leading players?
7.3. What strategies do leading players follow?
8 COMPANY PROFILES
8.1. Pfizer Inc.
8.2. A Menarini Industrie Farmaceutiche Riunite Srl
8.3. Recordati S.p.A.
8.4. Chiesi Farmaceutici SpA
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
LIST OF TABLES
Table 1: Italy pharmaceuticals market value: $ billion, 2017-22
Table 2: Italy pharmaceuticals market geography segmentation: $ billion, 2022
Table 3: Italy pharmaceuticals market value forecast: $ billion, 2022-27
Table 4: Pfizer Inc.: key facts
Table 5: Pfizer Inc.: Annual Financial Ratios
Table 6: Pfizer Inc.: Key Employees
Table 7: Pfizer Inc.: Key Employees Continued
Table 8: A Menarini Industrie Farmaceutiche Riunite Srl: key facts
Table 9: A Menarini Industrie Farmaceutiche Riunite Srl: Key Employees
Table 10: Recordati S.p.A.: key facts
Table 11: Recordati S.p.A.: Annual Financial Ratios
Table 12: Recordati S.p.A.: Key Employees
Table 13: Chiesi Farmaceutici SpA: key facts
Table 14: Chiesi Farmaceutici SpA: Key Employees
Table 15: Italy size of population (million), 2018-22
Table 16: Italy gdp (constant 2005 prices, $ billion), 2018-22
Table 17: Italy gdp (current prices, $ billion), 2018-22
Table 18: Italy inflation, 2018-22
Table 19: Italy consumer price index (absolute), 2018-22
Table 20: Italy exchange rate, 2018-22
Table 1: Italy pharmaceuticals market value: $ billion, 2017-22
Table 2: Italy pharmaceuticals market geography segmentation: $ billion, 2022
Table 3: Italy pharmaceuticals market value forecast: $ billion, 2022-27
Table 4: Pfizer Inc.: key facts
Table 5: Pfizer Inc.: Annual Financial Ratios
Table 6: Pfizer Inc.: Key Employees
Table 7: Pfizer Inc.: Key Employees Continued
Table 8: A Menarini Industrie Farmaceutiche Riunite Srl: key facts
Table 9: A Menarini Industrie Farmaceutiche Riunite Srl: Key Employees
Table 10: Recordati S.p.A.: key facts
Table 11: Recordati S.p.A.: Annual Financial Ratios
Table 12: Recordati S.p.A.: Key Employees
Table 13: Chiesi Farmaceutici SpA: key facts
Table 14: Chiesi Farmaceutici SpA: Key Employees
Table 15: Italy size of population (million), 2018-22
Table 16: Italy gdp (constant 2005 prices, $ billion), 2018-22
Table 17: Italy gdp (current prices, $ billion), 2018-22
Table 18: Italy inflation, 2018-22
Table 19: Italy consumer price index (absolute), 2018-22
Table 20: Italy exchange rate, 2018-22
LIST OF FIGURES
Figure 1: Italy pharmaceuticals market value: $ billion, 2017-22
Figure 2: Italy pharmaceuticals market geography segmentation: % share, by value, 2022
Figure 3: Italy pharmaceuticals market value forecast: $ billion, 2022-27
Figure 4: Forces driving competition in the pharmaceuticals market in Italy, 2022
Figure 5: Drivers of buyer power in the pharmaceuticals market in Italy, 2022
Figure 6: Drivers of supplier power in the pharmaceuticals market in Italy, 2022
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Italy, 2022
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in Italy, 2022
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in Italy, 2022
Figure 1: Italy pharmaceuticals market value: $ billion, 2017-22
Figure 2: Italy pharmaceuticals market geography segmentation: % share, by value, 2022
Figure 3: Italy pharmaceuticals market value forecast: $ billion, 2022-27
Figure 4: Forces driving competition in the pharmaceuticals market in Italy, 2022
Figure 5: Drivers of buyer power in the pharmaceuticals market in Italy, 2022
Figure 6: Drivers of supplier power in the pharmaceuticals market in Italy, 2022
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Italy, 2022
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in Italy, 2022
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in Italy, 2022
